Answering human papillomavirus vaccine concerns; a matter of science and time

Authors

David Hawkes, The University of Melbourne
Candice E. Lea, Flinders University
Matthew J. Berryman, University of WollongongFollow

RIS ID

79794

Publication Details

Hawkes, D., Lea, C. E. & Berryman, M. J. (2013). Answering human papillomavirus vaccine concerns; a matter of science and time. Infectious Agents and Cancer, 8 1-8.

Abstract

Since the introduction of the HPV vaccine, questions have been asked about its efficacy in preventing cancer linked with HPV. Concerns about the HPV vaccine safety profile have also been raised. This paper highlights the rapidly growing body of evidence (including clinical trials and post-marketing surveillance) illustrating both the safety of the HPV vaccine, through a detailed investigation of reported adverse events, and its efficacy in reducing both HPV infections rates and the resulting drop in cervical lesions, which have been demonstrated to be good predictors of cervical cancer risk.